Latest FDA Stories
Ginette Collazzo, Ph.D., an authority on industrial/organizational psychology, has recently developed new tools to measure, explain and predict human error from both process and cognitive load
Just because the last FDA/ISO inspection was passed, don’t be lulled into complacency.
With the Freedom portable driver powering the SynCardia Total Artificial Heart, patients are now able to choose alternative transportation other than driving to the hospital for their donor heart transplant. TUCSON,
Implant Marks Benvenue Medical's Entry into Expandable Lumbar Interbody Fusion Device Market SANTA CLARA, Calif., Dec.
Sanofi Commitment to Research and Develop TB Treatments, Diagnostics and Vaccines Spans More than 50 Years BRIDGEWATER, N.J., Dec.
Only FDA-approved and only Pregnancy Category A prescription treatment for Nausea and Vomiting of Pregnancy is now available in Tennessee through the state-administered Medicaid Drug Rebate Program
Companion Survey Suggests Psychological Toll of Diabetes SAN FRANCISCO, Dec.
Based on the results of the trial's pre-specified interim analysis all control patients in the EF-14 phase III trial will be offered the opportunity to cross over to receive Tumor Treating Fields
Represents Major Step In Company's Strategy to Target Large Multi-Billion-Dollar Market Opportunities MENLO PARK, Calif., Dec.
The agency says that the tools can spread a hidden uterine cancer, and advises against its use in the majority of women undergoing fibroid removal via hysterectomy or myomectomy.
- A poem in which the author retracts something said in an earlier poem.